原发性肝癌的治疗，首选手术，且效果最佳。但中晚期肝癌获得切除者仅占20％～30％，绝大多数患者失去手术的机会．非手术者中位生存期仅2．5个月。如何延长这些患者的生存期是目前迫切需要解决的问题。本院自1994年以来采用肝动脉插管化疗加碘油及明胶海绵栓塞治疗不能1期手术 For the treatment of primary liver cancer, the first choice is surgery and the best results are obtained. However, only 20% to 30% of patients with advanced liver cancer undergo resection, and most patients lose the chance of surgery. The median survival of non-operative patients was only 2.5 months. How to prolong the survival of these patients is an urgent problem that needs to be solved. This hospital has been using hepatic arterial intubation chemotherapy plus lipiodol and gelatin sponge embolization since 1994 to treat stage 1 surgery